As part of the Chinese Antibody Society’s webinar series, Finnegan partner Li Feng will consider antibody patent application drafting and PCT filing strategies. For more information, or to register, please see Chinese Antibody Society’s website.
At the PTAB Blog
Discretion All the Way Down: USPTO Uses a Discretionary IPR Denial to Justify a
§ 325(d) EPR Denial
May 28, 2026
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.